Pathology of Pulmonary Hypertension Wolter J. Mooi Department of Pathology, VUmc Amsterdam

Slides:



Advertisements
Similar presentations
Pulmonary Hypertension
Advertisements

VENTRICULAR SEPTAL DEFECT (VSD)
Tissue Fluid Formation and Oedema
Ipertensione polmonare
Respiratory Path III Dr Rotimi Adigun
RYAN O’GOWAN, MBA, PA-C FAPACVS FCCM Pulmonary Hypertension.
GI12.  The liver has a dual blood supply, which comes from the hepatic artery ( 25% of vascularization) and the portal vein ( 75% of vascularization).
AM Report Lauren Galpin, MD MA  “Thromboembolic obstruction of the major pulmonary arteries due to unresolved pulmonary embolism [with pulmonary.
Bosentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and post- pulmonary endarterectomy pulmonary hypertension A pre-defined subgroup.
CHEST X-RAY FINDINGS: Left-to-Right Shunt
VASCULAR DISORDERS OF THE LUNG PULMONARY OEDEMA PULMONARY EMBOLI / INFARCT PULMONARY HYPERTENSION PULMONARY HAEMORRHAGE & VASCULITIS.
Slide 1PUBLICATIONS Racusen/Solez meeting report for AJT. Racusen/Solez meeting report for AJT. Manuscript on antibody-mediated rejection. Manuscript on.
Pulmonary Vascular Disease. Pulmonary Circulatuion Dual supply  Pulmonary arteries  Bronchial arteries Low pressure system Pulmonary artery receives.
Cardiovascular System II. How do we measure blood pressure ?
Lupus Nephritis in Children Renal involvement in SLE: 30% - 70% Renal involvement in SLE: 30% - 70% Most diagnosis in adolescence, rare < 5y/o Most diagnosis.
Vascular Diseases of Lungs. Pulmonary Hypertension It is the increase in blood pressure in pulmonary arteries, veins and capillaries. It leads to shortness.
VENOUS THROMBOSIS & PUL.EMBOLISM : PROF.DR. MUHAMMAD AKBAR CHAUDHARY M.R.C.P. (U.K.) F.R.C.P. (E) F.R.C.P. (LONDON) F.A.C.C DESIGNED AT A.V. DEPT F.J.M.C.
Pulmonary Hypertension and Various Treatment Options
DR. HANA OMER CONGENITAL HEART DEFECTS. The major development of the fetal heart occurs between the fourth and seventh weeks of gestation, and most congenital.
1.Pulmonary Vascular Disease 2.Pleural Disease Prof. Frank Carey.
Dr. Meg-angela Christi M. Amores
Atrial and Ventricular Enlargement
Dean Handimulya UIEU 2005 Congestive Heart Failure Dean Handimulya, M.D.
The left frame shows marked narrowing as seen by angiography. The right frame shows the histology of the narrowed area. There is marked thickening of.
Pulmonary Hypertension
Cardiovascular practical Block Part I Shaesta Naseem.
Prof. Sevda Özdoğan  Pulmonary hypertension (PH) is characterized by elevated pulmonary arterial pressure and secondary right ventricular failure.
Respiratory Tutorial. Pulmonary oedema Causes –Haemodynamic Increased hydrostatic pressure –(heart failure, mitral stenosis, volume overload) Decreased.
Congestion.
Cardiac & Respiratory Dynamics. Vascular System Carry blood away from heart Arteries  Arterioles  Capillaries Carry blood to heart Capillaries  Venules.
Pulmonary Hypertension: Diagnostics and Therapeutics Presented by R3 林至芃
Pathology of Kidney and the Urinary tract
Katie DePlatchett M.D. AM Report June 29,  Elevated Pulmonary Artery pressure  Secondary R Ventricular failure  Mean Pulm Artery Pressure of.
1 Benign Nephrosclerosis Definition: renal changes in benign hypertension It is always associated with hyaline arteriolosclerosis. mild benign nephrosclerosis.
DISEASES OF THE HEART K.V.BHARATHI. Agenda: Normal heart. Heart failure. Congenital heart disease. Ischemic heart disease. Sudden cardiac death. Hypertensive.
5/98MedSlides.com1 Pulmonary (Arterial) Hypertension
What Causes Cor Pulmonale?
פרופ ' נוויל ברקמן מכון הריאה ביה " ח האוניברסיטאי הדסה עין - כרם PULMONARY HYPERTENSION AND COR PULMONALE פרופ ' נוויל ברקמן מכון הריאה ביה " ח האוניברסיטאי.
HYPERTENSIVE VASCULAR DISEASE. Cutoffs in diagnosing hypertension in clinical practice  sustained diastolic pressures >90 mm Hg, or sustained systolic.
ELAINE N. MARIEB EIGHTH EDITION 11 Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation by.
CONGENITAL HEART DEFECTS DR. HANA OMER. CONGENITAL HEART DEFECTS D. HANA OMER.
Cardiovascular practical Block
Differentiate Pulmonary arterial hypertension from pulmonary venous congestion.
Faculty of allied medical sciences
Cardiovascular Pathology
R1 정수웅.  Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive, fibrosing interstitial pneumonia of unknown cause that occurs.
WARM-UP 1. What is the pacemaker? Where is it located? 2. List the parts of the intrinsic conduction system of the heart. 3. Draw and label the 3 waves.
CARDIOVASCULAR SYSTEM Blood Vessels. BLOOD VESSELS Arteries function to carry blood away from heart Arteries function to carry blood away from heart The.
Pathology of pulmonary hypertension Dr.Ashraf Abdelfatah Deyab Assisstant Professor of Pathology Faculty of Medicine Almajma’ah University.
Effort Dependence of change in 6-Minute Walk Test in Pulmonary Hypertension was improved by Correction with the Change in Heart Rate: The Beat-Yield Pulmonology.
Workshop 11: CHD-ASD D4 Saldana, Sales, Salonga, San Diego, San Pedro, Sanez, Sanidad, Santos E., Santos J., Santos J., Santos K., Santos M.
CVC LUNG, LIVER AND SPLEEN
HYPEREMIA & CONGESTION II
HYPERTENSIVE HEART DISEASE (Hypertensive cardiomyopathy)
Mild degree of coronary athersclerosis
Congenital Heart Diseases
Left Ventricular Dysfunction With Pulmonary Hypertension
Warm-Up What is the pacemaker? Where is it located?
Circulatory System Section 14.1.
H M M IF Causes of Pulmonary Hypertension in Patients with Sarcoid Perivascular fibrosis Increased vasoreactivity Granulomas in pulmonary.
Structure and Function vessels
Pulmonary diseases of vascular origin
Blood Vessels & Circulation
Clinical-pathologic conference in thoracic surgery: Proximal pulmonary artery obstruction secondary to Takayasu arteritis  Thoralf M. Sundt, MD  The Journal.
Selection of patients: 248 consecutive patients with newly diagnosed pre-capillary pulmonary hypertension were included in the study. Selection of patients:
Pulmonary Hypertension (PH)
Pathology Of Hypertension
Establishment and comparison of two reliable hyperkinetic pulmonary hypertension models in rabbits  Chuanzhen Liu, MD, Zhibo Yan, MD, PhD, Changcun Fang,
Cardiovascular System
Presentation transcript:

Pathology of Pulmonary Hypertension Wolter J. Mooi Department of Pathology, VUmc Amsterdam

Pulmonary arterial hypertension (WHO definition) Sustained elevation of pulmonary arterial pressure to more than 25 mm Hg at rest, or to more than 30 mm Hg with exercise Mean pulmonary wedge pressure and left ventricular end-diastolic pressure less than 15 mm Hg

WHO Classification of Pulmonary Hypertension Group I: Pulmonary arterial hypertension –Idiopathic (primary) –Familial –Associated with significant venous or capillary involvement –Persistent pulmonary hypertension of the newborn Group II: Pulmonary venous hypertension –Left-sided artial or ventricular heart disease –Left-sided valvular heart disease Group III: Pulmonary hypertension associated with hypoxemia Group IV: Pulmonary hypertension due to chronic thrombotic disease, embolic disease, or both Group V: Miscellaneous

WHO Classification of Pulmonary Hypertension: criticisms Pulmonary arterial hypertension is not limited to Group I (this is inappropriately suggested by its designation as ‘pulmonary arterial hypertension’) –It may be associated with pulmonary venous hypertension –It may be posttrombotic (Group IV) or hypoxic (Group III) The group ‘miscellaneous’ includes: compression of pulmonary veins, which should be in Group II (pulmonary venous hypertension)

Main histological patterns of pulmonary hypertensive vascular disease Congestive vasculopathy –Backward failure of left side of heart –Obstruction of pulopmary large veins Hypoxic pulmonary vasculopathy –COPD, high altitude dwellers, alevoar hypoventialtion disorders, &c Postthrombotic pulmonary vasculopathy –Chronic recurrent thromboembolism, primary thrombosis Plexogenic pulmonary arteriopathy –Posttricuspid LR shunts; associated with anorexigens, HIV, portal hypertension, idiopathic Pulmonary vascular occlusive disease Miscellaneous rare disorders

Congestive pulmonary vasculopathy Veins: –Intimal fibrosis –Medial hypertrophy, ‘arterialization’ Interstitial fibrosis Haemosiderosis Arteries: –Intimal fibrosis –Medial hypertrophy –Adventitial thickening

Hypoxic pulmonary vasculopathy Arteries and arterioles : –Medial hypertrophy (accentuated in smaller branches) –Muscularization of arterioles –Longitudinal smooth muscle bundles –Mild intimal thickening Veins : –Mild thickening of venule walls (mild smooth medial hypertrophy, mild fibrosis)

Postthrombotic pulmonary arteriopathy Arteries: –Eccentric intimal fibrosis –Concentric intimal fibrosis (not concentric laminar) –Bands and webs –Medial atrophy, fibrosis –Arterial obliteration; fibroelastic scars NB-1: abnormalities are focal, so that many arteries may appear normal or near normal, even in the presence of severe obstruction NB-2: arterial changes in fibrosing lung disease are very similar if not identical to postthrombotic arteriopathy

Plexogenic pulmonary arteriopathy Early phase: –Medial thickening of elastic and muscular pulmonary arteries –Muscularization of pulmonary arterioles –Mild intimal fibrosis Late phase: –Concentric laminar intimal fibrosis –Fibrinoid necrosis, arteritis –Dilatation lesions –Plexifom lesions

BMPR2 germline mutations and familial pulmonary plexogenic arteriopathy Deng et al., Am J Hum Genet 2000; 67: ; Lane et al., Nat Genet 2000; 26: 81-84

BMPR2 and pulmonary plexogenic arteriopathy

Heath Edwards grading system of hypertensive pulmonary vasular disease in congenital cardiac septal defects (1958) Grade 1: retention of foetal-type pulmonary arteries Grade 2: medial hypertrophy with cellular intimal proliferation Grade 3: progressive fibrous vascular occlusion Grade 4: progressive generalized arterial dilatation with formation of dilatation lesions Grade 5: chronic dilatation with numerous dilatation lesions and pulmonary haemosiderosis Grade 6: necrotizing arteritis

Grade Intimal reaction NoneCellular proliferation Fibrous and fibroelastic changes Plexiform lesion Medial changes hypertrophy Some generalized dilatation Local dilatation lesions Haemosidereosis Necrotizing arteritis Heath Edwards grading system

Miscellaneous pulmonary hypertensive vasculopathies Sarcoidosis Langerhans cell histiocytosis Lymphangioleiomyomatosis Pulmonary vascular misalignment Pulmonary capillary hemangiomatosis Developmental abnormalities &c